Journal Article Summary
The article discusses a case involving a patient with multiple myeloma who developed progressive multifocal leucoencephalopathy (PML) after undergoing autologous bone marrow transplantation (ABMT). PML is a serious neurological condition caused by the JC virus, which can occur in immunocompromised individuals. Understanding the treatment options for PML is crucial, especially for patients who have undergone intensive therapies like chemotherapy and stem cell transplants, as they may be at higher risk for such complications.
The authors describe the case of a patient who, after receiving high-dose chemotherapy and two ABMTs, experienced severe neurological symptoms nine months later. Upon diagnosis of PML, the patient was treated with cidofovir and mirtazapine. Over a six-month period, her symptoms stabilized, and follow-up tests showed that the JC virus was no longer detectable in her cerebrospinal fluid. Additionally, MRI scans indicated that the volume of demyelinating lesions remained stable, suggesting that the treatment was effective in managing her condition.
Despite the positive outcomes observed in this case, there are limitations to consider. The findings are based on a single patient, which may not be generalizable to all individuals with PML. Patients and caregivers should discuss the potential risks and benefits of treatment options with healthcare professionals, especially in the context of PML and other complications following bone marrow transplantation. It is important to monitor neurological health closely and seek timely medical advice if new symptoms arise.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Ripellino P, Comi C, Mula M, Varrasi C, Conconi A, Stecco A, Brustia D, Nasuelli N, et al.. Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment option. BMJ Case Reports 2011. DOI: 10.1136/bcr.11.2010.3549. PMID: 22701032. PMCID: PMC3079531.
Featured Pill Pals Product
Mirtazapine 15 mg Tablets --- 30 Count --- Generic for Remeron --- Rising Pharma
Mirtazapine 15 mg Tablets — 30 Count — Generic for Remeron — Rising Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
